Abstract Details
Nancy J. Newman, MD, FAAN
(Emory University School of Medicine)
PRESENTER |
Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. |
Patrick Yu-Wai-Man | No disclosure on file |
Valerio Carelli, MD, PhD (University of Bologna) | Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici. |
Mark L. Moster, MD, FAAN (Neuro-Ophthalmology -Wills Eye Hospital) | Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kilcoyne and Nesbitt. |
No disclosure on file | |
Alfredo Sadun, MD (Doheny Eye Institute USC Sch.) | Dr. Sadun has received publishing royalties from a publication relating to health care. |
Chiara La Morgia, MD (University of Bologna) | Dr. La Morgia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regulatory Pharmanet s.r.l. . Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Santhera Pharmaceuticals. Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi Farmaceutici s.p.a.. The institution of Dr. La Morgia has received research support from Italian Ministry of Health. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Dean Cestari, MD | Dr. Cestari has nothing to disclose. |
Rod Foroozan | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Magali Taiel | No disclosure on file |
Jose-Alain Sahel | The institution of Jose-Alain Sahel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avista. The institution of Jose-Alain Sahel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tenpoint . The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF GENSIGHT. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF SPARINGVISION. Jose-Alain Sahel has stock in Prophesee. Jose-Alain Sahel has stock in Tilak Healthcare. Jose-Alain Sahel has stock in Sparing Vision. Jose-Alain Sahel has stock in Chronolife. Jose-Alain Sahel has stock in VegaVect Inc.. Jose-Alain Sahel has stock in Avista. Jose-Alain Sahel has stock in Tenpoint. Jose-Alain Sahel has stock in SharpEye. Jose-Alain Sahel has stock in GenSight. The institution of Jose-Alain Sahel has received research support from LabEx LIFESENSES (ANR-10-LABX-65). The institution of Jose-Alain Sahel has received research support from IHU FOReSIGHT (ANR-18-IAHU-01). The institution of Jose-Alain Sahel has received research support from ERC Synergy "HELMHOLTZ". Jose-Alain Sahel has received intellectual property interests from a discovery or technology relating to health care. |